Drilling Down Into Cheniere Energy, Inc. (LNG)

Cheniere Energy, Inc. (LNG) is an interesting player in the Basic Materials space, with a focus on Oil & Gas Pipelines. The stock has been active on the tape, currently trading at $61.97, down from yesterday’s close by -0.69%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Cheniere Energy, Inc. (LNG) currently trades with a market capitalization of $14.59 Billion. That value represents a market adjusting for revenues that have been growing by 85.14 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$1.42 Billion over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0.23 on a per share basis this quarter. Perhaps, that suggests something about why 4.60% of the outstanding share supply is held by institutional investors.

Technical Analysis

It’s important to check the technicals to get a sense of how LNG has been acting. Looking at the stock’s movement on the chart, Cheniere Energy, Inc. recorded a 52-week high of $63.97. It is now trading 2% off that level. The stock is trading $55.89 its 50-day moving average by -6.08%. The stock carved out a 52-week low down at $40.36.

In recent action, Cheniere Energy, Inc. (LNG) has made a move of +10.27% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 12.84, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 5.84% with $234.32 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of LNG.

Previous articleTaking a Fresh Look at Nektar Therapeutics (NKTR)
Next articleThe Case for and Against The Blackstone Group L.P. (BX)